The Other Side of the Transition: What Menopause Actually Is, and What It Means for Mental Health
Menopause is not a continuation of perimenopause — it is a different biological state with different mental health implications. Understanding what actually changes when you cross this threshold is the foundation for everything that follows.
By Dr. Julie Rashkis, Psy.D. | Licensed Psychologist | Menopause Society Certified Practitioner | therapyformidlife.com
'I thought menopause would be more of the same — hot flashes, mood swings, the whole thing, just continuing indefinitely. But something has shifted. Some of what was terrible has gotten better. And some things that weren't a problem before are new. I don't know what I'm in now or what to expect.'
This disorientation is extremely common — and it reflects a genuine gap in how menopause is explained to women. The public conversation about menopause tends to treat the entire midlife hormonal transition as one undifferentiated experience. In reality, perimenopause and menopause are neurobiologically distinct. The mental health implications of one are not the same as the mental health implications of the other. And the women who navigate this passage most effectively are the ones who understand what they are actually in.
This article — the first in the Menopause Mental Health Insights series — provides that foundation. It explains what menopause is and is not, what changes hormonally when the transition is complete, why some perimenopause symptoms improve while new ones can emerge, and what the psychological research says about mental health in the postmenopausal years. It is the map for everything that follows in this series.
What Menopause Actually Is
Menopause is defined clinically as 12 consecutive months without a menstrual period, in the absence of other medical causes. It is a retrospective diagnosis — you know you have reached menopause a year after it has occurred. The average age of natural menopause in the United States is 51 to 52, though the range is wide: natural menopause before 45 is considered early, and before 40 is considered premature ovarian
insufficiency, each with distinct clinical implications.
What menopause marks, biologically, is the completion of ovarian follicular depletion. The ovaries are no longer cycling — they are no longer producing the cyclic surges and fluctuations of estrogen and progesterone that characterized both the reproductive years and the perimenopausal transition. Estrogen does not disappear entirely; the adrenal glands continue to produce androgens that are converted to estrone (a weaker form of estrogen) in peripheral tissues, particularly fat. But the dominant, fluctuating estradiol of the reproductive years is gone — replaced by chronically low, stable estrone.
This is the critical neurobiological shift: from volatility to stability, but at a lower floor. Perimenopause is characterized by the erratic fluctuation of estrogen — the nervous system's distress comes largely from the instability, the unpredictability, the way the brain cannot calibrate to a hormone level that changes radically day to day. Postmenopause is characterized by a new, consistently low hormonal baseline. The volatility resolves. The floor is lower. Both facts matter — and they pull in opposite directions for mental health.
"Perimenopause is the storm — estrogen fluctuating wildly, the nervous system unable to calibrate. Menopause is the aftermath: a new, consistently lower baseline. Some symptoms resolve with the end of volatility. Others emerge because the floor itself is lower. Understanding which is which changes everything about how to respond."
What Improves — and Why
For many women, the completion of the menopause transition brings genuine relief — not because everything is better, but because the specific symptoms driven by hormonal volatility tend to improve when the volatility ends.
The rage, irritability, and emotional lability that characterize perimenopause for many women are substantially driven by the erratic fluctuation of estrogen's effects on serotonin, GABA, and the HPA axis. When estrogen is fluctuating unpredictably, the serotonin system and the stress response system are fluctuating with it. When estrogen stabilizes — even at a lower level — these systems can reach a new equilibrium. Many women describe the emotional volatility of perimenopause as lifting in the years following their final period. The anger that came from nowhere, the tearfulness that had no source, the sense of riding an emotional rollercoaster — these are often perimenopause phenomena, not postmenopause ones.
The AARP Menopause and Brain Health Survey (2025), one of the most recent large-scale assessments of postmenopausal women's wellbeing, found that women in the postmenopause stage fare significantly better than perimenopausal women on measures of stress, anxiety, depression, and mental wellbeing. The SWAN study similarly found that for many women, mood and cognitive symptoms that peaked during perimenopause improved as hormones stabilized postmenopausally. This is not universal — but it is common enough to be clinically meaningful, and it is almost never communicated to women who are in the midst of the worst of perimenopause.
Sleep, for many women, also improves postmenopausally — particularly for those whose sleep disruption was primarily driven by nocturnal hot flashes. As vasomotor symptoms tend to diminish over the postmenopausal years for most women (though not all), the sleep fragmentation that was their downstream effect often decreases with them.
What Can Emerge — and Why
The lower estrogen floor of postmenopause also creates new vulnerabilities that were not present in the same way during the reproductive years. Understanding these is not cause for alarm — it is cause for informed awareness and proactive care.
Depression in postmenopause follows a different pattern than perimenopausal depression. Perimenopausal depression is substantially driven by the instability of hormonal fluctuation — it characteristically fluctuates, has a strong mood-reactivity quality, and often improves when hormonal volatility resolves. Postmenopausal depression, in contrast, is driven by chronically low estrogen's sustained effects on serotonin and norepinephrine — two neurotransmitters that estrogen upregulates. Women with a history of mood sensitivity are at particular risk for a new depressive pattern postmenopausally, one that may look and respond differently from depression at earlier life stages. Article 2 of this series addresses this in detail.
Genitourinary symptoms — the cluster of vaginal, vulvar, and urinary changes driven by the loss of estrogen's effects on mucosal tissue — tend to emerge and often worsen in the postmenopausal years. Unlike vasomotor symptoms, which typically diminish over time, genitourinary syndrome of menopause (GSM) does not self-resolve without treatment. Its psychological burden — on body image, sexual functioning, intimate relationships, and sense of physical integrity — is one of the most underdiscussed mental health dimensions of postmenopause. Article 4 of this series addresses this directly.
Cognitive changes in postmenopause reflect a different pattern than perimenopausal brain fog. The erratic cognitive disruption of perimenopause — where estrogen fluctuation directly interfered with hippocampal function — typically improves with stabilization. What remains in postmenopause is the effect of the consistently lower estrogen floor on long-term cognitive aging, including the research on sex differences in Alzheimer's risk and what women can actually do about it. Article 7 of this series addresses the evidence carefully.
Perimenopause vs. Postmenopause: What Changes
The table below summarizes the key distinctions between perimenopause and postmenopause mental health — distinctions that matter for how symptoms are understood and treated.
Domain: Hormonal pattern
Perimenopause: Erratic fluctuation of estrogen and progesterone; highly unpredictable day to day
Postmenopause: Consistently low, stable estrone; volatility has resolved; new equilibrium
Domain: Mood pattern
Perimenopause: Emotional volatility, rage, tearfulness, rapid mood shifts driven by hormonal instability
Postmenopause: Emotional stabilization for many; risk of persistent low mood driven by chronically low estrogen floor
Domain: Anxiety pattern
Perimenopause: HPA hyperreactivity, panic-like symptoms, hypervigilance — driven by erratic estrogen affecting cortisol
Postmenopause: For many, anxiety improves; for some, a quieter, more ruminative anxiety emerges with the lower estrogen floor
Domain: Cognitive pattern
Perimenopause: Brain fog peaks during transition; word-finding, working memory most disrupted during volatility
Postmenopause: Cognitive disruption often improves; long-term estrogen-floor effects on cognitive aging become more relevant
Domain: Sleep
Perimenopause: Fragmented by nocturnal hot flashes, progesterone loss, and cortisol dysregulation
Postmenopause: Improves for many as vasomotor symptoms decline; GSM-related nocturia can emerge as a new disruptor
Domain: Vasomotor symptoms
Perimenopause: Peak frequency and severity during transition; can be severe and disabling
Postmenopause: Typically diminish over postmenopausal years for most women, though timeline varies considerably
Domain: Genitourinary
Perimenopause: May begin in late perimenopause; often not yet a primary concern
Postmenopause: GSM typically emerges and worsens without treatment; does not self-resolve; psychological burden significant
Domain: Primary driver of distress
Perimenopause: The volatility — the unpredictability, the inability of the nervous system to calibrate
Postmenopause: The floor — the sustained low estrogen level and its downstream effects on body, brain, and mood
The Psychological Meaning of Arrival
Reaching menopause is not only a biological event. It carries psychological weight that varies considerably depending on a woman's relationship to reproduction, to her body, and to the cultural narratives about aging and femininity that she has absorbed across her lifetime.
For some women, menopause represents relief — from the monthly cycle, from contraception concerns, from the physical demands of perimenopause. For others, it represents loss — the definitive closure of reproductive possibility, a marker of aging in a culture that has told them their value was tied to fertility and youth. For many, it is both simultaneously, often in ways that are difficult to articulate and rarely invited for discussion.
The grief that accompanies menopause — even when it is also a relief — deserves to be acknowledged rather than bypassed. Women are frequently told that menopause is 'natural' in a way that is meant to be reassuring but functions to foreclose grief. Natural events can still involve loss. A transition that closes doors — to pregnancy, to the body as it was, to the hormonal milieu that has been present since puberty — is a transition that deserves psychological space, not just medical management.
At the same time, the research on postmenopausal wellbeing documents something the cultural narrative systematically obscures: for a significant proportion of women, the years following menopause are
characterized by increased psychological freedom, clearer values, greater authenticity, and a relief from the people-pleasing and self-suppression that characterized earlier decades. Article 9 of this series addresses this research in depth. It is real, it is documented, and it is almost never told.
What This Series Covers — and Who It Is For
This is the first article in a 10-part series on menopause and mental health — a companion to the Perimenopause Mental Health Insights series, extending the clinical conversation into the postmenopausal years. The series covers:
Postmenopausal depression and its distinct presentation (Article 2). The shift in anxiety postmenopause, including the workplace dimension (Article 3). Genitourinary syndrome of menopause and its psychological burden (Article 4). Sexual health, desire, and intimacy after menopause (Article 5). Body image, weight, and the menopause body (Article 6). Cognitive health and Alzheimer's risk — what the research actually shows (Article 7). Relationships, couples, and how menopause reshapes partnerships (Article 8). The postmenopausal wellbeing data — the relief that doesn't get talked about (Article 9). And finally, when to seek help and what therapy offers in the menopause years (Article 10).
This series is for women who have reached menopause, or are approaching it, and who want the psychological dimension of this passage understood with the same depth and clinical seriousness as the hormonal one. It is for their partners, their clinicians, and anyone who cares for postmenopausal women and wants to do so more accurately.
And it is for the woman who has been told, in various ways, that she should be past the hard part — when the hard part has simply changed shape.
About the Author
Dr. Julie Rashkis is a licensed psychologist and Menopause Society Certified Practitioner with over 20 years of clinical experience. She specializes in the psychological dimensions of perimenopause and menopause — including the postmenopausal years that are so frequently underdiscussed in both clinical and public conversations. She is the founder of Therapy for Midlife, a virtual practice licensed in California and Wisconsin, seeing clients across all PSYPACT-participating states.
www.therapyformidlife.com | Book a free consultation
References
1. Harlow, S. D., et al. (2012). Executive summary of the Stages of Reproductive Aging Workshop +10. Menopause, 19(4), 387-395. [STRAW+10]
2. Avis, N. E., et al. (2015). Duration of menopausal vasomotor symptoms over the menopause transition. JAMA Internal Medicine, 175(4), 531-539. [SWAN]
3. AARP Public Policy Institute. (2025). Menopause and Brain Health: Women Ages 35-Plus. AARP Research. 4. Maki, P. M., & Thurston, R. C. (2020). Menopause and brain health: Hormonal changes are only part of the story. Frontiers in Neurology, 11, 562275.
5. Greendale, G. A., et al. (2009). Effects of the menopause transition and hormone use on cognitive performance in midlife women. Neurology, 72(21), 1850-1857. [SWAN]
6. Bromberger, J. T., & Epperson, C. N. (2018). Depression during and after the perimenopause: Impact of hormones, sleep, and menopause symptoms. Obstetrics and Gynecology Clinics of North America, 45(4), 663-678.
7. ScienceDirect. (2024). Neuroendocrine mechanisms of mood disorders during menopause transition: A narrative review. ScienceDirect. PMC.
8. Portman, D. J., & Gass, M. L. (2014). Genitourinary syndrome of menopause: New terminology for vulvovaginal atrophy. Menopause, 21(10), 1063-1068.
9. Brown, L., et al. (2024). Promoting good mental health over the menopause transition. The Lancet, 403(10430), 969-983. 10. Mitchell, E. S., & Woods, N. F. (2001). Midlife women's attributions about perceived memory changes. Journal of Women's Health and Gender-Based Medicine, 10(4), 351-362.
11. Freeman, E. W., & Sherif, K. (2007). Prevalence of hot flushes and night sweats around the world. Climacteric, 10(3), 197-214.
